logo
Plus   Neg
Share
Email

Novartis Reports Disappointing Results From LUSTER Studies With Fevipiprant

Novartis (NVS) said the topline results from global Phase III LUSTER-1 and LUSTER-2 studies did not support further development of Fevipiprant in asthma as a primary indication. The pooled analyses of the LUSTER trials did not meet the clinically relevant threshold for reduction in rate of moderate -to-severe exacerbation compared to placebo over a 52-week treatment period for either of the doses, 150mg / 450 mg. Fevipiprant was generally well tolerated in the study.

Fevipiprant is an investigational steroid-free once-daily pill. It blocks the DP2 pathway, a potentially important regulator of the asthma inflammatory cascade.

"While the results of the LUSTER studies with fevipiprant are disappointing, they meaningfully contribute to our understanding of the DP2 pathway in asthma," said John Tsai, Head Global Drug Development and Chief Medical Officer, Novartis.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Trade Commission (FTC) is in the process of sending out refund checks to consumers who were allegedly misled by Office Depot, Inc. and its software provider Support.com, Inc., into buying computer repair products and services. Out of $34 million, being the total amount of checks, Office Depot paid $25 million and Support.com paid $10 million as part of 2019 settlement. Gap Inc. partnered with fashion resale platform thredUP to facilitate the exchange of secondhand cloths. The retailer in a blog post said its customers can bring secondhand clothes in exchange for shopping credit that can be redeemed at Gap, Banana Republic, Athleta, or Janie and Jack. Customers who redeem their credits at Gap brands will receive an additional 15 percent payout bonus. Coca-Cola Co. (KO) on Friday reaffirmed its guidance for the full-year 2020 and provided an update on the expected impact from COVID-19 on first quarter 2020 results, ahead of its presentation at the Consumer Analyst Group of New York (CAGNY) Conference. For fiscal 2020, the company continues to project...
Follow RTT
>